MedTrace Logo

Mortality Related to AMR in Patients With Hospital-acquired Infection

NCT03411538 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2069

Last updated 2020-09-16

No results posted yet for this study

Summary

This is a prospective surveillance study to estimate excess deaths due to and risk factors associated with antibiotic-resistant infection among patients with hospital-acquired infection (HAI) in a resource-limited setting. We will focus on six pathogenic bacteria that are of clinically important in the hospital.

Conditions

  • Hospital-acquired Infections

Interventions

OTHER

Collect data on clinical history

Collect data on clinical history, clinical manifestation, comorbidity, admission data, use of invasive medical intervention, history of antibiotic treatment and antibiotic susceptibility test results

Sponsors & Collaborators

  • Sanpasitthiprasong Hospital

    collaborator OTHER_GOV

  • Mahidol Oxford Tropical Medicine Research Unit

    collaborator OTHER

  • University of Oxford

    lead OTHER

Principal Investigators

  • Assoc. Prof. Direk Limmathurotsakul, MD · Mahidol Oxford Tropical Medicine Research Unit

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-03-01
Primary Completion
2020-02-28
Completion
2020-02-28

Countries

  • Thailand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03411538 on ClinicalTrials.gov